An FDA-appointed panel has ruled that restrictions should be placed on the use of gadolinium contrast agents (commonly used in medical imaging scans) after convincing evidence has linked the agents to a potentially fatal skin-hardening disease called nephrogenic systemic fibrosis (NSF). Sources say that NSF is a progressive disease that can cause the skin to thicken and harden in the arms, legs, and extremities.

While the FDA does not have to follow the advice of it's appointed panels, sources say that a panel recommendation often goes a long way toward implementing new regulations. 

If you or someone you love has suffered NSF or other health problems caused by gadolinium contrast agents, contact the NSF attorneys of Williams Kherkher at 800-761-3187 today.

A British subsidiary of General Electric has been trying to prevent a doctor from reporting about the ill effects of the company's gadolinium drug.

According to British news reports, some of the doctor's kidney patients reported negative side effects of Omniscan. However, the lawsuit may prevent the doctor from making the allegations. 

If you or anyone you know has suffered negative effects from a gadolinium-based drug, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187.

Medical experts affiliated with the U.S. Food and Drug Administration will consider whether new warnings should be added to certain drugs, including drugs that contain gadolinium. 

The drugs in question are made by General Electric, Bayer AG, Covidien Plc and other drug manufacturers. These drugs generate hundreds of millions of dollars in sales each year and are often used for magnetic resonance imaging. 

If you or anyone you know has suffered ill side effects from taking a gadolinium-based contast agent, contact the NSF lawyers of Williams Kherkher at 800-761-3187.